Dr Sabrina Paganoni
Healey Center for ALS at Massachusetts General Hospital (MGH) and Harvard Medical School, USA
"Functional and long-term survival benefit of AMX0035 in ALS: Results of the CENTAUR and Open Label Extension trials"
Sabrina Paganoni, MD, PhD is a physician investigator at the Healey Center for ALS at Massachusetts General Hospital (MGH), Co-Director of the Neurological Research Institute at MGH and Assistant Professor at Harvard Medical School.
Dr Paganoni’s research focuses on clinical trials and therapy development for ALS. She has served as the Principal Investigator of many ALS clinical trials and has been using novel neuroimaging techniques, bio-fluid biomarkers and digital technology as measures of target engagement in these trials.
Currently, she is the co-Principal Investigator of the HEALEY ALS Platform Trial. Her research has been funded by the NIH, several ALS Foundations, and industry.